• ABSTRACT
    • The purpose of this study was to determine if the use of larger femoral head diameters, in combination with recent practice including enhanced soft tissue choices and various operative exposure choices has led to any further decline in dislocation rates. 51,901 patients undergoing primary THA were identified from 5% Medicare Part B (physician/carrier) claims between January 1, 1997 and December 31, 2011. Dislocation rate at 6 months following THA was 2.84% over the study period (1997-2011). From 2005 to 2011, dislocation rates following primary THA have plateaued in the United States at approximately 2%. This suggests that the full benefits using large femoral head sizes are now realized. For further improvement in dislocation rates, a greater emphasis will be required on patient selection, surgical technique and component alignment.